The clinical-stage biopharmaceutical firm is pushing its NMDA platform while building a national network of psychiatric ...

Outside of the FDA and Health Canada approved indications, Ketamine is also being administered in hospitals and clinics to treat various pain, neurological, and mental health disorders. A published ...

Specialty pharmaceutical company PharmaTher Holdings’ drug application for Ketamine has received a June 4 approval goal date, advancing approval of the drug in the U.S. PharmaTher said it is ...

A number of stop searches following positive indications from Polly resulted in the seizure of six grams of MDMA (ecstasy), five grams of cannabis and one gram of ketamine, said police.

The company also acquired the rights to Ketamir, which, in layman’s terms, is a potential derivative of the antidepressant ketamine that has shown indications of having fewer side effects ...